ArticleThe Journal of experimental medicine2018

CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.

Tal Teitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.